(Alliance News) - IP Group PLC on Friday said its portfolio company Microbiotica Ltd raised funds as it aims to advance its drug candidate into phase 2 clinical development. Read More
(Alliance News) - IP Group PLC on Tuesday reported increased net asset value amid a "supportive" investment climate, and said it commences its second half with "growing momentum". Read More
(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - Railways Pension Trustee Co Ltd on Monday said it won't make an offer for IP Group PLC, saying several months of negotiations have failed to yield an agreement. Read More
(Alliance News) - AstraZeneca affirmed annual guidance, while Vodafone lifted its outlook after the Safaricom deal. Elsewhere, DCC Energy has agreed to a takeover, Serica Energy will buy Pharos Energy but IP Group's suitor will not make an offer for the firm. Read More
(Alliance News) - IP Group PLC suitor Railways Pension Trustee Co Ltd said Friday it has made a sweetened proposal to acquire the investor in the science and technology sectors, following meetings with shareholders. Read More
(Alliance News) - IP Group PLC on Tuesday confirmed that it recently received an acquisition proposal from Railways Pension Trustee Co Ltd through its subsidiary, Railway Pension Investments Ltd. Read More
(Alliance News) - The FTSE 100 rose on Monday, and the pound made headway, as UK Prime Minister Keir Starmer confirmed he was stepping down and as talks between the US and Iran appeared to make progress. Read More
(Alliance News) - Railways Pension Trustee Company Ltd, or Railpen, on Monday said IP Group PLC has rejected its possible takeover offer worth GBP615.8 million. Read More
(Alliance News) - IP Group PLC on Tuesday announced that portfolio company Istesso has commenced dosing for the IST-03 trial of leramistat in sarcopenia caused by rheumatoid arthritis. Read More
(Alliance News) - IP Group PLC on Monday noted positive test results for a cystic fibrosis treatment developed by one of its portfolio firms. Read More
